FDA Inspection 1195016 — Howard A. Hassman, D.O.
The FDA completed an inspection of Howard A. Hassman, D.O. on Jan 17, 2023 in Marlton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 17, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Marlton, NJ (United States)
Additional details
Clinical BA/BE